Description
Jardiance (Empagliflozin) 10mg tablets are an oral medication used for the treatment of type 2 diabetes in adults. Jardiance belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by preventing the reabsorption of glucose by the kidneys, which leads to increased glucose excretion in urine and subsequently helps lower blood sugar levels. Additionally, Jardiance has been shown to reduce the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
Dosage/Direction
The recommended starting dose for Jardiance is typically 10mg once daily, which can be taken with or without food. Depending on the patient’s response and tolerability, the dosage may be increased to 25mg. It is important to take the medication at the same time each day to maintain consistent blood sugar control. Always follow the prescribing healthcare provider’s instructions regarding dosage and administration.
Side Effects
Common side effects of Jardiance may include urinary tract infections, genital fungal infections, increased urination, and dehydration. Some patients may experience symptoms such as dizziness or lightheadedness due to dehydration. Rare but serious side effects can include acute kidney injury, ketoacidosis, and serious allergic reactions. If patients experience symptoms such as severe abdominal pain, nausea, vomiting, or difficulty breathing, they should seek medical attention immediately.
